ArticleThe American journal of case reports2025
Diagnosis and Management of Autoimmune Hepatitis After Hepatitis A in a Young Woman.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Hepatitis A (Hep A) is a common cause of viral hepatitis in developing nations. Autoimmune hepatitis is characterized by subacute to chronic liver inflammation, which can lead to liver cirrhosis if untreated. Both conditions remain uncommon in the United States. Development of autoimmune hepatitis following viral Hep A is extremely rare. However, viral infections, including Hep A, have been implicated in triggering autoimmune diseases through immune system activation, molecular mimicry, and inflammatory cytokine surges. Early recognition of this phenomenon is crucial for timely intervention and improved outcomes. CASE REPORT A 32-year-old Hispanic woman with a history of Hep A presented to the emergency room with chief concerns of intermittent epigastric abdominal pain and jaundice for 2 weeks. Physical exam revealed scleral icterus with right upper-quadrant tenderness. Although abdominal imaging was concerning for gallbladder wall thickening, the degree of hyperbilirubinemia (10 mg/dL) and ALT (2100 U/L) elevation were out of proportion to that commonly seen with cholecystitis. The patient's condition deteriorated despite supportive treatment. Further investigations detected IgG against Hep A, positive anti-nuclear antibodies, and anti-smooth muscle antibodies. The liver biopsy confirmed autoimmune hepatitis. The patient showed rapid clinical improvement after initiation of intravenous steroids and was ultimately discharged home. CONCLUSIONS Autoimmune hepatitis developing after acute Hep A is rare. High clinical suspicion and prompt treatment with systemic steroids are key for rapid clinical improvement and preventing complications. Recognizing viral infections as potential autoimmune triggers may help guide earlier diagnosis and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.